# MiR-34a deficiency enhances nucleic acid sensing and type I IFN signaling in a mouse model of Alzheimer’s disease

**Authors:** Junling Yang, George Elliot Tsourdinis, Charlotte Holas, Mark Maienschein-Cline, Robert Lalonde, Ken-ichiro Fukuchi

PMC · DOI: 10.3389/fimmu.2026.1694824 · Frontiers in Immunology · 2026-02-24

## TL;DR

Deleting miR-34a in mice with Alzheimer's disease improved memory and altered brain inflammation pathways linked to interferon responses.

## Contribution

This study reveals miR-34a's novel role in regulating microglial interferon responses and Alzheimer's pathology in mice.

## Key findings

- MiR-34a knockout improved memory and altered amyloid-beta levels in Alzheimer's mice.
- MiR-34a deficiency increased activated microglia and interferon-stimulated gene expression in the brain.
- Knocking down miR-34a enhanced interferon responses in cultured microglial cells.

## Abstract

A number of microRNAs are implicated in aging, cell senescence, inflammation, and neurodegenerative diseases. Particularly, miR-34a levels in the brain are increased in Alzheimer's disease (AD) but its mechanistic role in AD pathogenesis is unknown.

In order to investigate the role of miR-34a in AD, we produced an AD mouse model, Tg-SwDI mice, with whole body/constitutive miR-34a knockout (KO). Their cognitive function was evaluated by Morris water maze. Immunohistochemistry and immunofluorescence were used for neuropathological evaluation. Bulk RNA-seq followed by bioinformatics was used for hippocampal transcriptomics. The effect of miR-34a knockdown on expression of interferon-stimulated genes (ISG) was determined using cultured microglial cells and quantitative PCR.

MiR-34a KO improved long-term memory in Tg-SwDI mice, which was associated with decreases in the ratio of insoluble Aβ42 to Aβ40 and with increases in soluble and insoluble Aβ40 in the cerebral cortex. Anti-Iba1 immunofluorescence revealed increases in activated microglia. Bulk RNA-sequencing of the hippocampus followed by a gene set enrichment analysis (Enrichr) identified “cellular response to type I interferon” and “type I interferon signaling pathway” as the most prominent gene sets in miR-34a KO Tg-SwDI mice compared to miR-34a wild-type Tg-SwDI mice. Many interferon-stimulated genes (ISGs) that characterize interferon responsive microglia (IRM) were upregulated in miR-34a KO Tg-SwDI mice. MiR-34a knockdown strongly enhanced ISGs expression in TLR7 ligand-stimulated BV2 and primary microglia.

Our results suggest that miR-34a inhibits the transition of microglia to the IRM state that may modulate synaptic and cognitive functions in neurodegenerative diseases and aging.

## Linked entities

- **Genes:** MIR34A (microRNA 34a) [NCBI Gene 407040]
- **Diseases:** Alzheimer's disease (MONDO:0004975)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Mir34a (microRNA 34a) [NCBI Gene 723848] {aka Mirn34a, mir-34a, mmu-mir-34a}, Tlr7 (toll-like receptor 7) [NCBI Gene 170743], Iba1 (induction of brown adipocytes 1) [NCBI Gene 114737]
- **Diseases:** inflammation (MESH:D007249), neurodegenerative diseases (MESH:D019636), AD (MESH:D000544)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12971419/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12971419/full.md

## References

82 references — full list in the complete paper: https://tomesphere.com/paper/PMC12971419/full.md

---
Source: https://tomesphere.com/paper/PMC12971419